A Pathogenetic Approach to the Management of Systemic Sclerosis (Scleroderma)
- 1 November 1990
- journal article
- review article
- Published by Wiley in International Journal of Dermatology
- Vol. 29 (9) , 616-622
- https://doi.org/10.1111/j.1365-4362.1990.tb02581.x
Abstract
No abstract availableThis publication has 73 references indexed in Scilit:
- Systemic scleroderma: Clinical and pathophysiologic aspectsJournal of the American Academy of Dermatology, 1988
- Mechanisms of Interaction of Peptide and Nonpeptide Vascular Neurotransmitter SystemsJournal of Cardiovascular Pharmacology, 1987
- The Calcium Messenger SystemNew England Journal of Medicine, 1986
- Progressive systemic sclerosis and S-adenosylmethionineClinical Rheumatology, 1985
- Controlled Double-Blind Trial of Nifedipine in the Treatment of Raynaud's PhenomenonNew England Journal of Medicine, 1983
- Mechanism of Action of Calcium-Channel-Blocking AgentsNew England Journal of Medicine, 1982
- Treatment of Raynaud's phenomenon by intravenous infusion of prostacyclin (PGI2)British Journal of Dermatology, 1982
- Reversal of Vascular and Renal Crises of Scleroderma by Oral Angiotensin-Converting-Enzyme BlockadeNew England Journal of Medicine, 1979
- Control of Hypertension and Reversal of Renal Failure in SclerodermaNew England Journal of Medicine, 1978
- Arterial thrombosis in sclerodermaBritish Journal of Dermatology, 1975